Zobrazeno 1 - 10
of 766
pro vyhledávání: '"Beachler DC"'
Autor:
Rebordosa C; RTI Health Solutions, Barcelona, Spain., Thomsen RW; Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark., Tave AK; Carelon Research, Wilmington, Delaware, USA., Madsen M; Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark., Beachler DC; Carelon Research, Wilmington, Delaware, USA., Martinez D; RTI Health Solutions, Barcelona, Spain., Garcia-Esteban R; RTI Health Solutions, Barcelona, Spain., Plana E; RTI Health Solutions, Barcelona, Spain., Tormos A; RTI Health Solutions, Barcelona, Spain., Farsani SF; Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany., Perez-Gutthann S; RTI Health Solutions, Barcelona, Spain., Pladevall-Vila M; RTI Health Solutions, Barcelona, Spain.; The Center for Health Policy and Health Services Research, Henry Ford Health System, Detroit, Michigan, USA.
Publikováno v:
Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Apr; Vol. 26 (4), pp. 1291-1304. Date of Electronic Publication: 2024 Jan 17.
Autor:
Sponholtz T; Carelon Research, Wilmington, Delaware, USA., Jamal-Allial A; Carelon Research, Wilmington, Delaware, USA., Vojjala SK; Carelon Research, Wilmington, Delaware, USA., Papazian A; Carelon Research, Wilmington, Delaware, USA., Eshete B; Carelon Research, Wilmington, Delaware, USA., Paullin M; Carelon Research, Wilmington, Delaware, USA., Mahmoudpour SH; Merck Healthcare KGaA, Darmstadt, Germany., Verpillat P; Merck Healthcare KGaA, Darmstadt, Germany., Beachler DC; Carelon Research, Wilmington, Delaware, USA.
Publikováno v:
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2024 Aug; Vol. 33 (8), pp. e5870.
Autor:
Danysh HE; Department of Pharmacoepidemiology and Risk Management, RTI Health Solutions, 307 Waverley Oaks Road, Suite 101, Waltham, MA, 02452-8413, USA. hdanysh@rti.org., Johannes CB; Department of Pharmacoepidemiology and Risk Management, RTI Health Solutions, 307 Waverley Oaks Road, Suite 101, Waltham, MA, 02452-8413, USA., Beachler DC; Department of Safety and Epidemiology, HealthCore, Inc., Wilmington, DE, USA., Layton JB; Department of Pharmacoepidemiology and Risk Management, RTI Health Solutions, Research Triangle Park, NC, USA., Ziemiecki R; Department of Biostatistics, RTI Health Solutions, Research Triangle Park, NC, USA., Arana A; Department of Pharmacoepidemiology and Risk Management, RTI Health Solutions, Barcelona, Spain., Dinh J; Department of Research Operations, HealthCore, Inc., Wilmington, DE, USA., Li L; Department of Safety and Epidemiology, HealthCore, Inc., Wilmington, DE, USA., Calingaert B; Department of Pharmacoepidemiology and Risk Management, RTI Health Solutions, Research Triangle Park, NC, USA., Pladevall-Vila M; Department of Pharmacoepidemiology and Risk Management, RTI Health Solutions, Barcelona, Spain.; The Center for Health Policy and Health Services Research, Henry Ford Health System, Detroit, MI, USA., Hunt PR; BioPharmaceuticals Business Unit, AstraZeneca, Gaithersburg, MD, USA., Chen H; BioPharmaceuticals Business Unit, AstraZeneca, Gaithersburg, MD, USA., Karlsson C; BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Johnsson K; BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Gilsenan A; Department of Pharmacoepidemiology and Risk Management, RTI Health Solutions, Research Triangle Park, NC, USA.
Publikováno v:
Drug safety [Drug Saf] 2023 Feb; Vol. 46 (2), pp. 175-193. Date of Electronic Publication: 2022 Dec 30.
Autor:
Hu M; Acumen LLC, Burlingame, California., Shoaibi A; US Food and Drug Administration, Silver Spring, Maryland., Feng Y; Acumen LLC, Burlingame, California., Lloyd PC; US Food and Drug Administration, Silver Spring, Maryland., Wong HL; US Food and Drug Administration, Silver Spring, Maryland., Smith ER; Acumen LLC, Burlingame, California., Amend KL; Optum Epidemiology, Boston, Massachusetts., Kline A; CVS Health/Aetna, Blue Bell, Pennsylvania., Beachler DC; Carelon Research, Wilmington, Delaware., Gruber JF; US Food and Drug Administration, Silver Spring, Maryland., Mitra M; Acumen LLC, Burlingame, California., Seeger JD; Optum Epidemiology, Boston, Massachusetts., Harris C; CVS Health/Aetna, Blue Bell, Pennsylvania., Secora A; IQVIA, Falls Church, Virginia., Obidi J; US Food and Drug Administration, Silver Spring, Maryland., Wang J; Acumen LLC, Burlingame, California., Song J; Optum Epidemiology, Boston, Massachusetts., McMahill-Walraven CN; CVS Health/Aetna, Blue Bell, Pennsylvania., Reich C; IQVIA, Falls Church, Virginia., McEvoy R; Acumen LLC, Burlingame, California., Do R; Acumen LLC, Burlingame, California., Chillarige Y; Acumen LLC, Burlingame, California., Clifford R; Optum Epidemiology, Boston, Massachusetts., Cooper DD; CVS Health/Aetna, Blue Bell, Pennsylvania., Forshee RA; US Food and Drug Administration, Silver Spring, Maryland., Anderson SA; US Food and Drug Administration, Silver Spring, Maryland.
Publikováno v:
JAMA network open [JAMA Netw Open] 2024 Apr 01; Vol. 7 (4), pp. e248192. Date of Electronic Publication: 2024 Apr 01.
Autor:
Anthony MS; RTI Health Solutions, Research Triangle Park, NC., Aroda VR; Brigham and Women's Hospital, Boston, MA., Parlett LE; Carelon Research, Wilmington, DE., Djebarri L; Sanofi, Chilly-Mazarin, France., Berreghis S; Sanofi, Chilly-Mazarin, France., Calingaert B; RTI Health Solutions, Research Triangle Park, NC., Beachler DC; Carelon Research, Wilmington, DE., Crowe CL; Carelon Research, Wilmington, DE., Johannes CB; RTI Health Solutions, Waltham, MA., Juhaeri J; Sanofi, Inc., Bridgewater, NJ., Lanes S; Carelon Research, Wilmington, DE., Pan C; Sanofi, Inc., Bridgewater, NJ., Rothman KJ; RTI Health Solutions, Waltham, MA., Saltus CW; RTI Health Solutions, Waltham, MA., Walsh KE; Boston Children's Hospital, Boston, MA.
Publikováno v:
Diabetes care [Diabetes Care] 2024 Apr 01; Vol. 47 (4), pp. 712-719.
Autor:
Lloyd PC; US Food and Drug Administration, Silver Spring, MD, USA. Electronic address: patricia.lloyd@fda.hhs.gov., Lufkin B; Acumen LLC, Burlingame, CA, USA., Moll K; IBM Consulting, Bethesda, MD, USA., Ogilvie RP; Optum Epidemiology, Boston, MA, USA., McMahill-Walraven CN; CVS Health, Blue Bell, PA, USA., Beachler DC; Carelon Research, Wilmington, DE, USA., Kelman JA; Centers for Medicare & Medicaid Services, Baltimore, MD, USA., Shi X; Acumen LLC, Burlingame, CA, USA., Hobbi S; IBM Consulting, Bethesda, MD, USA., Amend KL; Optum Epidemiology, Boston, MA, USA., Djibo DA; CVS Health, Blue Bell, PA, USA., Shangguan S; Acumen LLC, Burlingame, CA, USA., Shoaibi A; US Food and Drug Administration, Silver Spring, MD, USA., Sheng M; IBM Consulting, Bethesda, MD, USA., Secora A; IQVIA, Falls Church, VA, USA., Zhou CK; US Food and Drug Administration, Silver Spring, MD, USA., Kowarski L; IBM Consulting, Bethesda, MD, USA., Chillarige Y; Acumen LLC, Burlingame, CA, USA., Forshee RA; US Food and Drug Administration, Silver Spring, MD, USA., Anderson SA; US Food and Drug Administration, Silver Spring, MD, USA., Muthuri S; IBM Consulting, Bethesda, MD, USA., Seeger JD; Optum Epidemiology, Boston, MA, USA., Kline A; CVS Health, Blue Bell, PA, USA., Reich C; IQVIA, Falls Church, VA, USA., MaCurdy T; Acumen LLC, Burlingame, CA, USA; Department of Economics, Stanford University, Stanford, CA, USA., Wong HL; US Food and Drug Administration, Silver Spring, MD, USA.
Publikováno v:
Vaccine [Vaccine] 2024 Mar 19; Vol. 42 (8), pp. 2004-2010. Date of Electronic Publication: 2024 Feb 22.
Autor:
Lanes S; Department of Safety and Epidemiology, HealthCore, Wilmington, Delaware, USA., Beachler DC; Department of Safety and Epidemiology, HealthCore, Wilmington, Delaware, USA.
Publikováno v:
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2023 Jun; Vol. 32 (6), pp. 700-703. Date of Electronic Publication: 2023 Feb 23.
Autor:
Johannes CB; Department of Pharmacoepidemiology and Risk Management, RTI Health Solutions, 307 Waverley Oaks Road, Suite 101, Waltham, MA, 02452, USA. cjohannes@rti.org., Beachler DC; Department of Safety and Epidemiology, HealthCore, Inc., Wilmington, DE, USA., Layton JB; Department of Pharmacoepidemiology and Risk Management, RTI Health Solutions, Research Triangle Park, NC, USA., Danysh HE; Department of Pharmacoepidemiology and Risk Management, RTI Health Solutions, 307 Waverley Oaks Road, Suite 101, Waltham, MA, 02452, USA., Ziemiecki R; Department of Biostatistics, RTI Health Solutions, Research Triangle Park, NC, USA., Arana A; Department of Pharmacoepidemiology and Risk Management, RTI Health Solutions, Barcelona, Spain., Dinh J; Department of Safety and Epidemiology, HealthCore, Inc., Wilmington, DE, USA.; Department of Research Operations, HealthCore, Inc., Wilmington, DE, USA., Li L; Department of Safety and Epidemiology, HealthCore, Inc., Wilmington, DE, USA., Calingaert B; Department of Pharmacoepidemiology and Risk Management, RTI Health Solutions, Research Triangle Park, NC, USA., Pladevall-Vila M; Department of Pharmacoepidemiology and Risk Management, RTI Health Solutions, Barcelona, Spain.; The Center for Health Policy and Health Services Research, Henry Ford Health System, Detroit, MI, USA., Hunt PR; BioPharmaceuticals Business Unit, AstraZeneca, Gaithersburg, MD, USA., Chen H; BioPharmaceuticals Business Unit, AstraZeneca, Gaithersburg, MD, USA., Karlsson C; BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Johnsson K; BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Gilsenan A; Department of Pharmacoepidemiology and Risk Management, RTI Health Solutions, Research Triangle Park, NC, USA.
Publikováno v:
Drug safety [Drug Saf] 2023 Feb; Vol. 46 (2), pp. 157-174. Date of Electronic Publication: 2022 Dec 17.
Autor:
Hoffman SR; From the Carelon Research (formerly HealthCore, Inc.), Safety & Epidemiology, Wilmington, DE., Governor S; From the Carelon Research (formerly HealthCore, Inc.), Safety & Epidemiology, Wilmington, DE., Daniels K; From the Carelon Research (formerly HealthCore, Inc.), Safety & Epidemiology, Wilmington, DE., Seals RM; Optum Epidemiology, Boston, MA., Ziyadeh NJ; Optum Epidemiology, Boston, MA., Wang FT; Optum Epidemiology, Boston, MA., Dai D; CVS Health Clinical Trial Services LLC (CVSH CTS; formerly Healthagen LLC), Blue Bell, PA., Mcmahill-Walraven CN; CVS Health Clinical Trial Services LLC (CVSH CTS; formerly Healthagen LLC), Blue Bell, PA., Shuminski P; CVS Health Clinical Trial Services LLC (CVSH CTS; formerly Healthagen LLC), Blue Bell, PA., Frajzyngier V; Pfizer, New York, NY., Zhou X; Pfizer, New York, NY., Shen R; Pfizer, New York, NY., Garg RK; Pfizer, New York, NY., Fournakis N; From the Carelon Research (formerly HealthCore, Inc.), Safety & Epidemiology, Wilmington, DE., Lanes S; From the Carelon Research (formerly HealthCore, Inc.), Safety & Epidemiology, Wilmington, DE., Beachler DC; From the Carelon Research (formerly HealthCore, Inc.), Safety & Epidemiology, Wilmington, DE.
Publikováno v:
Menopause (New York, N.Y.) [Menopause] 2023 Aug 01; Vol. 30 (8), pp. 824-830. Date of Electronic Publication: 2023 Jul 11.
Autor:
Hu M; Acumen, Burlingame, California., Wong HL; US Food and Drug Administration, Silver Spring, Maryland., Feng Y; Acumen, Burlingame, California., Lloyd PC; US Food and Drug Administration, Silver Spring, Maryland., Smith ER; Acumen, Burlingame, California., Amend KL; Optum Epidemiology, Boston, Massachusetts., Kline A; CVS Health Clinical Trial Services, Blue Bell, Pennsylvania., Beachler DC; HealthCore, Wilmington, Delaware., Gruber JF; US Food and Drug Administration, Silver Spring, Maryland., Mitra M; Acumen, Burlingame, California., Seeger JD; Optum Epidemiology, Boston, Massachusetts., Harris C; CVS Health Clinical Trial Services, Blue Bell, Pennsylvania., Secora A; IQVIA, Falls Church, Virginia., Obidi J; US Food and Drug Administration, Silver Spring, Maryland., Wang J; Acumen, Burlingame, California., Song J; Optum Epidemiology, Boston, Massachusetts., McMahill-Walraven CN; CVS Health Clinical Trial Services, Blue Bell, Pennsylvania., Reich C; IQVIA, Falls Church, Virginia., McEvoy R; Acumen, Burlingame, California., Do R; Acumen, Burlingame, California., Chillarige Y; Acumen, Burlingame, California., Clifford R; Optum Epidemiology, Boston, Massachusetts., Cooper DD; CVS Health Clinical Trial Services, Blue Bell, Pennsylvania., Shoaibi A; US Food and Drug Administration, Silver Spring, Maryland., Forshee R; US Food and Drug Administration, Silver Spring, Maryland., Anderson SA; US Food and Drug Administration, Silver Spring, Maryland.
Publikováno v:
JAMA pediatrics [JAMA Pediatr] 2023 Jul 01; Vol. 177 (7), pp. 710-717.